BMJ 1997;314:783 (15 March)

Papers

Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study

Mari-Anne Gall, research fellow,a Philip Hougaard, statistician,c Knut Borch-Johnsen, chief physician,b Hans-Henrik Parving, chief physician a

a Steno Diabetes Center DK 2820 Gentofte Denmark, b Centre of Preventive Medicine Glostrup University Hospital DK 2600 Glostrup Denmark, c Statistics Novo Nordisk DK 2880 Bagsvaerd Denmark

Correspondence to: Dr Gall

Objective: To evaluate putative risk factors for the development of incipient diabetic nephropathy (persistent microalbuminuria) and overt diabetic nephropathy (persistent macroalbuminuria) in patients with non-insulin dependent diabetes.
Design: Prospective, observational study of a cohort of white, non-insulin dependent diabetic patients followed for a median period of 5.8 years.
Setting: Outpatient clinic in tertiary referral centre.
Subjects: 191 patients aged under 66 years with non-insulin dependent diabetes and normoalbuminuria (urinary albumin excretion rate<30 mg/24 h) who attended the clinic during 1987.
Main outcome measures: Incipient and overt diabetic nephropathy.
Results: Fifteen patients were lost to follow up. Thirty six of the 176 remaining developed persistent microalbuminuria (30-299 mg/24 h in two out of three consecutive 24 hour urine collections) and five developed persistent macroalbuminuria (>=300 mg/24 h in two out of three consecutive collections) during follow up. The five year cumulative incidence of incipient diabetic nephropathy was 23% (95% confidence interval 17% to 30%). Cox's multiple stepwise regression analysis revealed the following risk factors for the development of incipient or overt diabetic nephropathy: increased baseline log urinary albumin excretion rate (relative risk 11.1 (3.4 to 35.9); P<0.0001); male sex (2.6 (1.2 to 5.4); P<0.02); presence of retinopathy (2.4 (1.3 to 4.7); P<0.01); increased serum cholesterol concentration (1.4 (1.1 to 1.7); P<0.01); haemoglobin A1c concentration (1.2 (1.0 to 1.4); P<0.05); and age (1.07 (1.02 to 1.12); P<0.01). Known duration of diabetes, body mass index, arterial blood pressure, serum creatinine concentration, pre-existing coronary heart disease, and history of smoking were not risk factors.
Conclusion: Several potentially modifiable risk factors predict the development of incipient and overt diabetic nephropathy in normoalbuminuric patients with non-insulin dependent diabetes.

Key messages

  • This study found a five year cumulative incidence of incipient diabetic nephropathy (persistent microalbuminuria, urinary albumin excretion rate between 30 and 299 mg/24 h) of 23% in white patients with non-insulin dependent diabetes mellitus

  • Potentially modifiable risk factors, such as increased urinary albumin excretion rate, long term poor glycaemic control, and hypercholesterolaemia predict the later development of incipient and overt diabetic nephropathy in these patients

  • Elderly, non-insulin dependent diabetic men with diabetic retinopathy are at increased risk of developing incipient or overt diabetic nephropathy

  • Known duration of diabetes, obesity, arterial blood pressure, serum creatinine concentration, pre-existing coronary heart disease, and history of smoking do not seem to act as risk factors


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Bilous, R., Chaturvedi, N., Sjolie, A. K., Fuller, J., Klein, R., Orchard, T., Porta, M., Parving, H.-H. (2009). Effect of Candesartan on Microalbuminuria and Albumin Excretion Rate in Diabetes: Three Randomized Trials. ANN INTERN MED 151: 11-20 [Abstract] [Full text]  
  • Maric, C. (2009). Sex, diabetes and the kidney. Am. J. Physiol. Renal Physiol. 296: F680-F688 [Abstract] [Full text]  
  • Yilmaz, M. I., Axelsson, J., Sonmez, A., Carrero, J. J., Saglam, M., Eyileten, T., Caglar, K., Kirkpantur, A., Celik, T., Oguz, Y., Vural, A., Yenicesu, M., Lindholm, B., Stenvinkel, P. (2009). Effect of Renin Angiotensin System Blockade on Pentraxin 3 Levels in Type-2 Diabetic Patients With Proteinuria. CJASN 4: 535-541 [Abstract] [Full text]  
  • American Diabetes Association, (2009). Standards of Medical Care in Diabetes--2009. Diabetes Care 32: S13-S61 [Full text]  
  • American Diabetes Association, (2008). Standards of Medical Care in Diabetes--2008. Diabetes Care 31: S12-S54 [Full text]  
  • Saito, K., Sone, H., Kawai, K., Tanaka, S., Kodama, S., Shu, M., Suzuki, E., Kondo, K., Yamamoto, S., Shimano, H., Ohashi, Y., Yamada, N. (2007). Risk Imparted by Various Parameters of Smoking in Japanese Men With Type 2 Diabetes on Their Development of Microalbuminuria: Analysis from the Tsukuba Kawai Diabetes Registry. Diabetes Care 30: 1286-1288 [Full text]  
  • Brantsma, A. H., Atthobari, J., Bakker, S. J.L., de Zeeuw, D., de Jong, P. E., Gansevoort, R. T., for the PREVEND Study Group, (2007). What Predicts Progression and Regression of Urinary Albumin Excretion in the Nondiabetic Population?. J. Am. Soc. Nephrol. 18: 637-645 [Abstract] [Full text]  
  • American Diabetes Association, (2007). Standards of Medical Care in Diabetes--2007. Diabetes Care 30: S4-S41 [Full text]  
  • Costacou, T., Chang, Y., Ferrell, R. E., Orchard, T. J. (2006). Identifying Genetic Susceptibilities to Diabetes-related Complications among Individuals at Low Risk of Complications: An Application of Tree-Structured Survival Analysis. Am J Epidemiol 164: 862-872 [Abstract] [Full text]  
  • Hansen, T. K., Gall, M.-A., Tarnow, L., Thiel, S., Stehouwer, C. D., Schalkwijk, C. G., Parving, H.-H., Flyvbjerg, A. (2006). Mannose-binding lectin and mortality in type 2 diabetes.. Arch Intern Med 166: 2007-2013 [Abstract] [Full text]  
  • Retnakaran, R., Cull, C. A., Thorne, K. I., Adler, A. I., Holman, R. R., for the UKPDS Study Group, (2006). Risk Factors for Renal Dysfunction in Type 2 Diabetes: U.K. Prospective Diabetes Study 74. Diabetes 55: 1832-1839 [Abstract] [Full text]  
  • Parvanova, A. I., Trevisan, R., Iliev, I. P., Dimitrov, B. D., Vedovato, M., Tiengo, A., Remuzzi, G., Ruggenenti, P. (2006). Insulin resistance and microalbuminuria: a cross-sectional, case-control study of 158 patients with type 2 diabetes and different degrees of urinary albumin excretion.. Diabetes 55: 1456-1462 [Abstract] [Full text]  
  • De, P., Das, G., Harley, K., Nair, H. (2006). Review: Dual blockade of renin-angiotensin system in diabetic nephropathy: review of literature and local experience. British Journal of Diabetes & Vascular Disease 6: 23-28 [Abstract]  
  • American Diabetes Association, (2006). Standards of Medical Care in Diabetes-2006. Diabetes Care 29: S4-S42 [Full text]  
  • Zhou, H., Isaman, D. J.M., Messinger, S., Brown, M. B., Klein, R., Brandle, M., Herman, W. H. (2005). A Computer Simulation Model of Diabetes Progression, Quality of Life, and Cost. Diabetes Care 28: 2856-2863 [Abstract] [Full text]  
  • Leitao, C. B., Canani, L. H., Bolson, P. B., Molon, M. P., Pinotti, A. F., Gross, J. L. (2005). Urinary Albumin Excretion Rate Is Associated With Increased Ambulatory Blood Pressure in Normoalbuminuric Type 2 Diabetic Patients. Diabetes Care 28: 1724-1729 [Abstract] [Full text]  
  • Parving, H.-H., Mogensen, C.E., Thomas, M.C., Brenner, B.M., Cooper, M.E., for the RENAAL study investigators, (2005). Poor prognosis in proteinuric type 2 diabetic patients with retinopathy: insights from the RENAAL study. QJM 98: 119-126 [Abstract] [Full text]  
  • Gross, J. L., de Azevedo, M. J., Silveiro, S. P., Canani, L. H., Caramori, M. L., Zelmanovitz, T. (2005). Diabetic Nephropathy: Diagnosis, Prevention, and Treatment. Diabetes Care 28: 164-176 [Abstract] [Full text]  
  • American Diabetes Association, (2005). Standards of Medical Care in Diabetes. Diabetes Care 28: S4-S36 [Full text]  
  • Ruggenenti, P., Fassi, A., Ilieva, A. P., Bruno, S., Iliev, I. P., Brusegan, V., Rubis, N., Gherardi, G., Arnoldi, F., Ganeva, M., Ene-Iordache, B., Gaspari, F., Perna, A., Bossi, A., Trevisan, R., Dodesini, A. R., Remuzzi, G., the Bergamo Nephrologic Diabetes Complications Tri, (2004). Preventing Microalbuminuria in Type 2 Diabetes. NEJM 351: 1941-1951 [Abstract] [Full text]  
  • Marshall, S M (2004). Recent advances in diabetic nephropathy. Postgrad. Med. J. 80: 624-633 [Abstract] [Full text]  
  • Polhill, T. S., Saad, S., Poronnik, P., Fulcher, G. R., Pollock, C. A. (2004). Short-term peaks in glucose promote renal fibrogenesis independently of total glucose exposure. Am. J. Physiol. Renal Physiol. 287: F268-F273 [Abstract] [Full text]  
  • Hovind, P., Tarnow, L., Rossing, P., Jensen, B. R., Graae, M., Torp, I., Binder, C., Parving, H.-H. (2004). Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. BMJ 328: 1105- [Abstract] [Full text]  
  • Wong, T. Y., Shankar, A., Klein, R., Klein, B. E.K. (2004). Retinal Vessel Diameters and the Incidence of Gross Proteinuria and Renal Insufficiency in People With Type 1 Diabetes. Diabetes 53: 179-184 [Abstract] [Full text]  
  • (2004). Standards of Medical Care in Diabetes. Diabetes Care 27: s15-35 [Full text]  
  • Boulware, L. E., Jaar, B. G., Tarver-Carr, M. E., Brancati, F. L., Powe, N. R. (2003). Screening for Proteinuria in US Adults: A Cost-effectiveness Analysis. JAMA 290: 3101-3114 [Abstract] [Full text]  
  • Svensson, M., Sundkvist, G., Arnqvist, H. J., Bjork, E., Blohme, G., Bolinder, J., Henricsson, M., Nystrom, L., Torffvit, O., Waernbaum, I., Ostman, J., Eriksson, J. W. (2003). Signs of Nephropathy May Occur Early in Young Adults With Diabetes Despite Modern Diabetes Management: Results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care 26: 2903-2909 [Abstract] [Full text]  
  • (2003). Standards of Medical Care for Patients With Diabetes Mellitus. Diabetes Care 26: S33-S50 [Full text]  
  • Knudsen, S. T., Bek, T., Poulsen, P. L., Hove, M. N., Rehling, M., Mogensen, C. E. (2002). Macular Edema Reflects Generalized Vascular Hyperpermeability in Type 2 Diabetic Patients With Retinopathy. Diabetes Care 25: 2328-2334 [Abstract] [Full text]  
  • Trevisan, R., Vedovato, M., Mazzon, C., Coracina, A., Iori, E., Tiengo, A., Del Prato, S. (2002). Concomitance of Diabetic Retinopathy and Proteinuria Accelerates the Rate of Decline of Kidney Function in Type 2 Diabetic Patients. Diabetes Care 25: 2026-2031 [Abstract] [Full text]  
  • Jude, E.B., Anderson, S.G., Cruickshank, J.K., Srivatsa, A., Tentolouris, N., Chandrasekaran, R., Gokal, R., Boulton, A.J.M. (2002). Natural history and prognostic factors of diabetic nephropathy in type 2 diabetes. QJM 95: 371-377 [Abstract] [Full text]  
  • Murussi, M., Baglio, P., Gross, J. L., Silveiro, S. P. (2002). Risk Factors for Microalbuminuria and Macroalbuminuria in Type 2 Diabetic Patients: A 9-year follow-up study. Diabetes Care 25: 1101-1103 [Full text]  
  • Mauer, M., Drummond, K. (2002). The Early Natural History of Nephropathy in Type 1 Diabetes: I. Study Design and Baseline Characteristics of the Study Participants. Diabetes 51: 1572-1579 [Abstract] [Full text]  
  • Jager, A., Kostense, P. J., Nijpels, G., Dekker, J. M., Heine, R. J., Bouter, L. M., Donker, A. J. M., Stehouwer, C. D. A. (2001). Serum Homocysteine Levels Are Associated With the Development of (Micro)albuminuria : The Hoorn Study. Arterioscler. Thromb. Vasc. Bio. 21: 74-81 [Abstract] [Full text]  
  • Melville, A, Richardson, R, Lister-Sharp, D, McIntosh, A (2000). Complications of diabetes: renal disease and promotion of self-management. Qual Saf Health Care 9: 257-263 [Full text]  
  • LEMLEY, K. V., BLOUCH, K., ABDULLAH, I., BOOTHROYD, D. B., BENNETT, P. H., MYERS, B. D., NELSON, R. G. (2000). Glomerular Permselectivity at the Onset of Nephropathy in Type 2 Diabetes Mellitus. J. Am. Soc. Nephrol. 11: 2095-2105 [Abstract] [Full text]  
  • (1998). Other Articles Noted. Evid. Based Nurs. 1: 100-104 [Full text]  
  • British Cardiac Society, , British Hyperlipidaemia Association, , British Hypertension Society, , endorsed by the British Diabetic Association, (1998). Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart 80: 1S-29 [Full text]  



Access jobs at BMJ Careers
Whats new online at Student 

BMJ